Mast cell activation in children with migraine before and after training in self-regulation

Headache

Volumn 39, Issue 2, 1999, Pages 101-107

  Olness, Karen ^a   Hall, Howard ^a   Rozniecki, Jacek J ^b   Schmidt, Wendy ^a   Theoharides, T C ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Mast cells; Migraine; Relaxation; Tryptase

Indexed keywords

TRYPTASE;

ARTICLE; AUTOREGULATION; CELL ACTIVATION; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; FEEDBACK SYSTEM; FEMALE; HEADACHE; HISTAMINE RELEASE; HUMAN; MALE; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; MIGRAINE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TRAINING;

EID: 0033031394     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1999.3902101.x     Document Type: Article

References (31)

1. Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261:2211-2216.
2. Lee LH, Olness KN. Clinical and demographic characteristics of migraine in urban children. Headache. 1997;37:269-276.
3. Winner P, Martinez W, Mate L, Bello L. Classification of pediatric migraine: proposed revisions to the IHS criteria. Headache. 1995;35:407-410.
4. Lundberg PO. Abdominal migraine - diagnosis and therapy. Headache. 1975;15:122-125.
5. Jernigan SA, Ware LM. Reversible quantitative EEG changes in a case of cyclic vomiting: evidence for migraine equivalent. Dev Med Child Neuraol. 1991;33:80-85.
6. Duckro PN, Cantwell-Simmons E. A review of studies evaluating biofeedback and relaxation training in the management of pediatric headache. Headache. 1989;29:428-433.
7. Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987;79:593-597.
8. Dooley J, Bagnell A. The prognosis and treatment of headaches in children - a ten year follow-up. Can J Neurol Sci. 1995;22:47-49.
9. Engel JM, Rapoff MA, Pressman AR. Long-term follow-up of relaxation training for pediatric headache disorders. Headache. 1992;32:152-156.
10. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996;384:560-564.
11. Theoharides TC. Mast cells: the immune gate to the brain. Life Sci. 1990;46:607-617.
12. Theoharides TC. Mast cells and migraines. Perspect Biol Med. 1983;26:672-675.
13. Theoharides TC. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React. 1996;18:1-21.
14. Heatley RV, Denburg JA, Bayer N, Bienenstock J. Increased plasma histamine levels in migraine patients. Clin Allergy. 1982;12:145-149.
15. Olesen J, Thomson LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci. 1994;15:149-153.
16. Olness K, Kohen D. Hypnosis and Hypnotherapy With Children. 3rd ed. New York: Guilford Press; 1996.
17. el-Mansoury M, Boucher W, Sant GR, Theoharides TC. Increased urine histamine and methylhistamine in interstitial cystitis. J Urol. 1994;152:350-353.
18. Boucher W, el-Mansoury M, Pang X, Sant GR, Theoharides TC. Elevated mast cell tryptase in the urine of patients with interstitial cystitis. Br J Urol. 1995;76:94-100.
19. Mansfield LE. The role of food allergy in migraine: a review. Ann Allergy. 1987;58:313-317.
20. Monro J, Carini C, Brostoff J. Migraine is a food-allergic disease. Lancet. 1984;2:719-721.
21. Speer F. Allergy and migraine: a clinical study. Headache. 1971;11:63-67.
22. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 1992;13:307-311.
23. Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC. Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mater mast cells. Neuroscience. 1991;44:97-112.
24. Anthony M, Lance JW. Histamine and serotonin in cluster headache. Arch Neurol. 1971;25:225-231.
25. Lee TJ, Saito A, Berezin I. Vasoactive intestinal polypeptide-like substance: the potential transmitter for cerebral vasodilation. Science. 1984;224:898-901.
26. Theoharides TC, Spanos C, Pang X, et al. Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology. 1995;136:5745-5750.
27. Theoharides TC, Singh LK, Boucher W, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology. 1998;139:403-413.
28. Sicuteri F. Mast cells and their active substances: their role in the pathogenesis of migraine. Headache. 1963;3:86-92.
29. Horton BT. Histaminic cephalgia. Lancet. 1952; 72:92-98.
30. Liberski PP, Mirecka B. Mast cells in cluster headache. Ultrastructure, release pattern and possible pathogenetic significance. Cephalalgia. 1984;4:101-106.
31. Dimitriadou V, Henry P, Brochet B, Mathiau P, Aubineau P. Cluster headache: ultrastructural evidence for mast cell degranulation and interaction with nerve fibres in the human temporal artery. Cephalalgia. 1990;10:221-228.